Human milk can neutralize Coxsackievirus B4 in vitro

Journal of Medical Virology

Volumn 85, Issue 5, 2013, Pages 880-887

  Sane, F ^a   Alidjinou, E K ^a   Kacet, N ^b   Moukassa, D ^c   Charlet, C ^b   Ebatetou Ataboho, E ^c   Ngoulou, W ^c   Badia Boungou, F ^c   Romond, M B ^d   Hober, D ^a  

^a University Lille   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Hopital Loandjili   (Congo)

^d UNIV LILLE   (France)

Author keywords

Antiviral activity, in vitro; Breast milk; Coxsackievirus B; Type 1 diabetes

Indexed keywords

IMMUNOGLOBULIN A; JACALIN;

ANTIVIRAL ACTIVITY; ARTICLE; BREAST MILK; COLOSTRUM; CONGO; COXSACKIE VIRUS B4; CYTOPATHOGENIC EFFECT; FRANCE; HEP 2 CELL; HUMAN; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; VIRUS NEUTRALIZATION;

ANTIBODIES, NEUTRALIZING; CONGO; ENTEROVIRUS B, HUMAN; FEMALE; FRANCE; HUMANS; IMMUNOGLOBULIN A; MILK, HUMAN; NEUTRALIZATION TESTS; PLASMA;

COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS B;

EID: 84875639326     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23518     Document Type: Article

References (38)

1. Akao Y, Sasagawa A, Shiga S, Kono R. 1971. Comparative studies on the mode of neutralization reaction of poliovirus type 2 with serum IgG and secretory IgA from mother's milk and fecal extract. Jpn J Med Sci Biol 24:135-152.
2. Araujo ED, Goncalves AK, Cornetta Mda, C, Cunha H, Cardoso ML, Morais SS, Giraldo PC. 2005. Evaluation of the secretory immunoglobulin A levels in the colostrum and milk of mothers of term and pre-term newborns. Braz J Infect Dis 9:357-362.
3. Asensi MT, Martinez-Costa C, Buesa J. 2006. Anti-rotavirus antibodies in human milk: Quantification and neutralizing activity. J Pediatr Gastroenterol Nutr 42:560-567.
4. Basolo F, Conaldi PG, Fiore L, Calvo S, Toniolo A. 1993. Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: Defective IL6 expression in mammary carcinoma. Int J Cancer 55:926-930.
5. Bessaud M, Pillet S, Ibrahim W, Joffret ML, Pozzetto B, Delpeyroux F, Gouandjika-Vasilache I. 2012. Molecular characterization of human enteroviruses in the Central African Republic: Uncovering wide diversity and identification of a new human enterovirus A71 genogroup. J Clin Microbiol 50:1650-1658.
6. Bjorksten B, Burman LG, De Chateau P, Fredrikzon B, Gothefors L, Hernell O. 1980. Collecting and banking human milk: To heat or not to heat? BMJ 281:765-769.
7. Cello J, Svennerholm B. 1994. Detection of enterovirus-specific total and polymeric IgA antibodies in serum using a synthetic peptide or heated virion antigen in ELISA. J Virol 44:422-427.
8. Duijts L, Ramadhani MK, Moll HA. 2009. Breastfeeding protects against infectious diseases during infancy in industrialized countries. A systematic review. Matern Child Nutr 5:199-210.
9. Gindrat JJ, Gothefors L, Hanson LA, Winberg J. 1972. Antibodies in human milk against E. Coli of the serogroups most commonly found in neonatal infections. Acta Paediatr Scand 61:587-590.
10. Hanson ML, Wendorff WL, Houck KB. 2005. Effect of heat treatment of milk on activation of Bacillus spores. J Food Prot 68:1484-1486.
11. Herrera-Insua I, Gomez HF, Diaz-Gonzalez VA, Chaturvedi P, Newburg DS, Cleary TG. 2001. Human milk lipids bind Shiga toxin. Adv Exp Med Biol 501:333-339.
12. Hober D, Sane F. 2011. Enteroviruses and type 1 diabetes. BMJ 342:c7072.
13. Hober D, Sauter P, Pathogenesis of type 1 diabetes mellitus. 2010. Interplay between enterovirus and host. Nat Rev Endocrinol 6:279-289.
14. Hyöty H, Hiltunen M, Knip M, Laakkonen M, Vähäsalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T. 1995. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes. 44:652-657.
15. Isaacs CE, Kashyap S, Heird WC, Thormar H. 1990. Antiviral and antibacterial lipids in human milk and infant formula feeds. Arch Dis Child 65:861-864.
16. Jaidane H, Hober D. 2008. Role of Coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 34:537-548.
17. Jaidane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. 2010. Enteroviruses and type 1 diabetes: Towards a better understanding of the relationship. Rev Med Virol 20:265-280.
18. Kondoh H, Kobayashi K, Hagiwara K. 1987. A simple procedure for the isolation of human secretory IgA of IgA1 and IgA2 subclass by a jackfruit lectin, jacalin, affinity chromatography. Mol Immunol 24:1219-1222.
19. Lonnrot M, Korpela K, Knip M, Ilonen J, Simell O, Korhonen S, Savola K, Muona P, Simell T, Koskela P, Hyöty H. 2000. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: The Finnish Diabetes Prediction and Prevention Study. Diabetes 49:1314-1318.
20. Malcova H, Sumnik Z, Drevinek P, Venhacova J, Lebl J, Cinek O. 2006. Absence of breast-feeding is associated with the risk of type 1 diabetes: A case-control study in a population with rapidly increasing incidence. Eur J Pediatr 165:114-119.
21. McLean B, Holmes IH. 1980. Transfer of antirotaviral antibodies from mothers to their infants. J Clin Microbiol 12:320-325.
22. Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Guerrero ML, Meinzen-Derr JK, Morrow AL. 2004. Human milk alphal, 2-linked fucosylated oligosaccharides decrease risk of diarrhea due to stable toxin of E. Coli in breastfed infants. Adv Exp Med Biol 554:457-461.
23. Pallansch MA, Roos RP. 2006. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Knipe DM, editors. Fields virology 2007 5th edition. Lippincott, PA: Williams & Williams, pp 839-894.
24. Ramírez-Santana C, Pérez-Cano FJ, Audí C, Castell M, Moretones MG, López-Sabater MC, Castellote C, Franch A. 2012. Effects of cooling and freezing storage on the stability of bioactive factors in human colostrum. J Dairy Sci. 95:2319-2325.
25. Raptopoulou-Gigi M, Marwick K, McClelland DB. 1977. Antimicrobial proteins in sterilised human milk. BMJ 1:12-14.
26. Roque-Barreira MC, Campos-Neto A. 1985. Jacalin: An IgA-binding lectin. J Immunol 134:1740-1743.
27. Roque-Berreira MC, Praz F, Halbwachs-Mecarelli L, Greene LJ, Campos-Neto A. 1986. IgA-affinity purification and characterization of the lectin jacalin. Braz J Med Biol Res 19:149-157.
28. Sadauskaite-Kuehne V, Ludvigsson J, Padaiga Z, Jasinskiene E, Samuelsson U. 2004. Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood. Diabetes Metab Res Rev 20:150-157.
29. Sadeharju K, Hamalainen AM, Knip M, Lonnrot M, Koskela P, Virtanen SM, Ilonen J, Akerblom HK, Hyoty H. 2003. Enterovirus infections as a risk factor for type I diabetes: Virus analyses in a dietary intervention trial. Clin Exp Immunol 132:271-277.
30. Sadeharju K, Knip M, Virtanen SM, Savilahti E, Tauriainen S, Koskela P, Akerblom HK, Hyoty H. 2007. Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 119:941-946.
31. Sakaguchi M, Tomomasa T, Kuroume T. 1995. Cytolytic action of stored human milk on blood cells in vitro. J Perinat Med 23:293-300.
32. Sanchez L, Calvo M, Brock JH. 1992. Biological role of lactoferrin. Arch Dis Child 67:657-661.
33. Sane F, Moumna I, Hober D. 2011. Group B coxsackieviruses and autoimmunity: Focus on Type 1 diabetes. Expert Rev Clin Immunol 7:357-366.
34. Schack-Nielsen L, Larnkjaer A, Michaelsen KF. 2005. Long term effects of breastfeeding on the infant and mother. Adv Exp Med Biol 569:16-23.
35. van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. 2001. Antiviral activities of lactoferrin. Antiviral Res 52:225-239.
36. Witso E, Cinek O, Aldrin M, Grinde B, Rasmussen T, Wetlesen T, Ronningen KS. 2010. Predictors of sub-clinical enterovirus infections in infants: A prospective cohort study. Int J Epidemiol 39:459-468.
37. Yeung WC, Rawlinson WD, Craig ME. 2011. Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies. BMJ 342:d35.
38. Yin H, Berg AK, Tuvemo T, Frisk G. 2002. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 51:1964-1971.